Loblaw to invest over $2 billion to open more than 40 additional stores
BRAMPTON, ON – Loblaw Cos., Canada’s food and pharmacy retail leader, expects to invest more than $2 billion dollars into the Canadian economy in 2024.
CDR
Cepham introduces Senolytics inspired by Ayurveda and TCM for sustainable aging
Cepham, a leader in Ayurvedic nutraceuticals research and sustainable self-care solutions, has announced the expansion of its Sustainable Aging product line to include senolytics, aimed at redefining approaches to healthy aging.
CVS beats Q4 sales and earnings projections
CVS Health topped analysts’ forecasts for fourth quarter sales and profits, but cut its full year earnings outlook, citing rising medical costs that are hurting the insurance industry. Revenue for the three months ended December 31 climbed 11.9% from the year-ago period to $93.
Discount Drug Mart adds self-service registration kiosk
Discount Drug Mart, the regional chain that “Saves you the Run Around,” is now saving time on vehicle registration renewals.
WBA beats Q1 projections, cuts dividend
Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades.
NACDS praises House passage of bipartisan bill to help deliver essential PBM reforms in Medicaid
NACDS is applauding the passage of the Lower Costs, More Transparency Act (H.R. 5378) by the U.S. House of Representatives today. The bill — which was introduced by U.S. Representative Cathy McMorris Rodgers (R-WA) on September 8 — is a vital aspect of pharmacy benefit manager (PBM) reform.
Dr. Reddy’s partners with Coya to develop ALS treatment
Dr. Reddy’s Laboratories is collaborating with Coya Therapeutics Inc. to develop and commercialize an investigational combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Coya has granted Dr.
Lilly’s Omvoh now available in the U.S. for ulcerative colitis
The Food and Drug Administration has approved Eli Lilly and Co.’s Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), as the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
CVS’ Q3 sales and profits beat forecasts
CVS Health topped Wall Street’s estimates for third quarter revenue and earnings. Adjusted earnings per share of $2.21 exceeded analysts’ predicted $2.13, while revenue of $89.76 billion beat the forecast of $88.2 billion.
Rite Aid files for Chapter 11 bankruptcy protection
Rite Aid Corp. on Sunday announced that it has filed for Chapter 11 bankruptcy protection as part of a voluntary restructuring plan that the company says will reduce its debt, increase its financial flexibility, and allow it to accelerate its ongoing business transformation.
Edgewell names Langley chief people and legal officer
SHELTON, Conn. _ LaTanya Langley has been appointed to the newly created post of chief people and legal officer at Edgewell Personal Care Co., effective November 6. Langley has been the company’s chief legal officer.
Hy-Vee makes Iowa a scintillating retailing center
If you happen to find yourself with a few idle days on your hands (How silly: Retailers seldom have a few extra days on their hands), you just might want to wander over to Des Moines, capital of Iowa, to examine how Hy-Vee, one of the truly stunning retailers this or any country has to
CVS pharmacies in Kansas City unaffected by strike threat
CVS pharmacies here were unaffected Wednesday by a threatened pharmacist walkout. The threat was reported by USA Today, which also had a story about a pharmacist walkout in the area over the weekend.
NACDS teams to launch Nourish My Health campaign
WASHINGTON – The National Association of Chain Drug Stores (NACDS) – along with leading health organizations the American Cancer Society, the American Diabetes Association (ADA), the American Heart Association, and the Food is Medicine Institute at the Friedman School of Nutrition Science and Policy
Kenvue to unveil two new products at PainWeek Conference
Kenvue Inc., the world’s largest pure-play consumer health company by revenue, announced Thursday that it will showcase new topical Tylenol Precise Pain Relieving Cream – the first U.S.